The novel kinase inhibitor EMD1214063 is effective against neuroblastoma

Guideline discordance in the use of radiographic imaging during initial workup of patients with prostate cancer (CaP).

(2017) Aaron David Falchook et al.   JOURNAL OF CLINICAL ONCOLOGY

Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells

(2013) Magali Humbert et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition

(2013) R. Katayama et al.   CANCER RESEARCH

The emerging role of MET/HGF inhibitors in oncology

(2013) Giorgio V. Scagliotti et al.   CANCER TREATMENT REVIEWS

EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors

(2013) F. Bladt et al.   CLINICAL CANCER RESEARCH

Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET

(2013) C. Basilico et al.   CLINICAL CANCER RESEARCH

The genetic landscape of high-risk neuroblastoma

(2013) Trevor J Pugh et al.   NATURE GENETICS

Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4

(2012) R. Srivastava et al.   CANCER RESEARCH

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines

(2011) E Arriola et al.   BRITISH JOURNAL OF CANCER

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

(2011) Wendy B. London et al.   JOURNAL OF CLINICAL ONCOLOGY

The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan

(2010) Peter E. Zage et al.   CANCER

Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo

(2010) Kristen N. Richards et al.   CANCER

PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells

(2009) Hal E Crosswell et al.   BMC CANCER

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

(2009) Katherine K. Matthay et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group

(2008) Peter E. Zage et al.   PEDIATRIC BLOOD & CANCER